Down Syndrome Disintegrative Disorder: New-Onset Autistic Regression, Dementia, and Insomnia in Older Children and Adolescents With Down Syndrome
- PMID: 25367918
- DOI: 10.1177/0883073814554654
Down Syndrome Disintegrative Disorder: New-Onset Autistic Regression, Dementia, and Insomnia in Older Children and Adolescents With Down Syndrome
Abstract
Over a 10-year period in a Down syndrome Clinic, 11 children and adolescents were encountered with a history of new-onset (8) or worsening (3) autistic characteristics. Ten of the 11 (91%) had cognitive decline to a dementia-like state and 9 of the 11 (82%) new-onset insomnia. The mean age at which symptoms developed was 11.4 years (standard deviation = 3.6 years; range 5-14 years), an older age than usual for autistic regression in Down syndrome. Ten of 11 cases (91%) had elevated ("positive") thyroperoxidase antibody titers compared to only 5 of 21 (23%) age-matched control subjects with Down syndrome (P < .001). At follow-up at a mean age of 20.7 years (standard deviation = 3.9 years), 8 of the 11 (73%) were at least somewhat better. Down syndrome disintegrative disorder seems an appropriate name for this newly recognized clinical association, which may be due to autoimmunity.
Keywords: Down syndrome; Hashimoto; autism; catatonia; disintegrative disorder; insomnia; thyroperoxidase antibody.
© The Author(s) 2014.
Similar articles
-
Difference in age at regression in children with autism with and without Down syndrome.J Dev Behav Pediatr. 2008 Apr;29(2):89-93. doi: 10.1097/DBP.0b013e318165c78d. J Dev Behav Pediatr. 2008. PMID: 18367994
-
Immunotherapy in selected patients with Down syndrome disintegrative disorder.Dev Med Child Neurol. 2019 Jul;61(7):847-851. doi: 10.1111/dmcn.14127. Epub 2018 Dec 12. Dev Med Child Neurol. 2019. PMID: 30548468
-
Down Syndrome Disintegrative Disorder: A Clinical Regression Syndrome of Increasing Importance.Pediatrics. 2020 Jun;145(6):e20192939. doi: 10.1542/peds.2019-2939. Pediatrics. 2020. PMID: 32471843 Review.
-
Childhood disintegrative disorder: distinction from autistic disorder and predictors of outcome.J Child Neurol. 2013 Dec;28(12):1587-98. doi: 10.1177/0883073812472391. Epub 2013 Jan 22. J Child Neurol. 2013. PMID: 23340080
-
Catatonia among adolescents with Down syndrome: a review and 2 case reports.J ECT. 2011 Dec;27(4):334-7. doi: 10.1097/YCT.0b013e31821d37c6. J ECT. 2011. PMID: 21673586 Review.
Cited by
-
Case report: Evolution of catatonic mutism and psychotic symptoms in an adolescent with Down syndrome: transition from Down syndrome disintegrative disorder to anti-N-methyl-D-aspartate receptor encephalitis.Front Neurol. 2023 Jun 9;14:1200541. doi: 10.3389/fneur.2023.1200541. eCollection 2023. Front Neurol. 2023. PMID: 37360353 Free PMC article.
-
Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder.Res Sq [Preprint]. 2023 Feb 13:rs.3.rs-2521595. doi: 10.21203/rs.3.rs-2521595/v1. Res Sq. 2023. Update in: Transl Psychiatry. 2023 Aug 8;13(1):276. doi: 10.1038/s41398-023-02579-z. PMID: 36824719 Free PMC article. Updated. Preprint.
-
Outcome Measures for Clinical Trials in Down Syndrome.Am J Intellect Dev Disabil. 2017 May;122(3):247-281. doi: 10.1352/1944-7558-122.3.247. Am J Intellect Dev Disabil. 2017. PMID: 28452584 Free PMC article.
-
A Systematic Review of Unexplained Early Regression in Adolescents and Adults with Down Syndrome.Brain Sci. 2021 Sep 10;11(9):1197. doi: 10.3390/brainsci11091197. Brain Sci. 2021. PMID: 34573218 Free PMC article. Review.
-
Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder.Ann Clin Transl Neurol. 2024 Apr;11(4):1034-1045. doi: 10.1002/acn3.52023. Epub 2024 Feb 20. Ann Clin Transl Neurol. 2024. PMID: 38375538 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical